Managing Director at Accenture
COVID has educated us about drug development, testing, approval, administration and post launch study processes. All these steps to development clinical trials to real-world care heavily use data – generating data from various sources, analyzing them for efficacy and adverse reactions during, and post, trial. But without a solution to seamlessly manage and analyze these datasets together, the process can become manually intensive and delay the time-to-market and understanding of a drug. In this presentation, the Denodo partner will discuss how life sciences companies increasingly need to blend clinical trial and real-world data with a logical data fabric.